Asian Journal of Transfusion Science

ORIGINAL ARTICLE
Year
: 2016  |  Volume : 10  |  Issue : 2  |  Page : 136--139

Alloimmunization in multitransfused liver disease patients: Impact of underlying disease


Meenu Bajpai1, Shruti Gupta1, Priyanka Jain2 
1 Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi, India
2 Department of Research, Institute of Liver and Biliary Sciences, New Delhi, India

Correspondence Address:
Meenu Bajpai
Department of Transfusion Medicine, Institute of Liver and Biliary Sciences, New Delhi
India

Introduction: Transfusion support is vital to the management of patients with liver diseases. Repeated transfusions are associated with many risks such as transfusion-transmitted infection, transfusion immunomodulation, and alloimmunization. Materials and Methods: A retrospective data analysis of antibody screening and identification was done from February 2012 to February 2014 to determine the frequency and specificity of irregular red-cell antibodies in multitransfused liver disease patients. The clinical and transfusion records were reviewed. The data was compiled, statistically analyzed, and reviewed. Results: A total of 842 patients were included in our study. Alloantibodies were detected in 5.22% of the patients. Higher rates of alloimmunization were seen in patients with autoimmune hepatitis, cryptogenic liver disease, liver damage due to drugs/toxins, and liver cancer patients. Patients with alcoholic liver disease had a lower rate of alloimmunization. The alloimmunization was 12.7% (23/181) in females and 3.17% (21/661) in males. Antibodies against the Rh system were the most frequent with 27 of 44 alloantibodies (61.36%). The most common alloantibody identified was anti-E (11/44 cases, 25%), followed by anti-C (6/44 cases, 13.63%). Conclusion: Our findings suggest that alloimmunization rate is affected by underlying disease. Provision of Rh and Kell phenotype-matched blood can significantly reduce alloimmunization.


How to cite this article:
Bajpai M, Gupta S, Jain P. Alloimmunization in multitransfused liver disease patients: Impact of underlying disease.Asian J Transfus Sci 2016;10:136-139


How to cite this URL:
Bajpai M, Gupta S, Jain P. Alloimmunization in multitransfused liver disease patients: Impact of underlying disease. Asian J Transfus Sci [serial online] 2016 [cited 2021 Sep 21 ];10:136-139
Available from: https://www.ajts.org/article.asp?issn=0973-6247;year=2016;volume=10;issue=2;spage=136;epage=139;aulast=Bajpai;type=0